Potentiation of cyclic AMP‐mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat
- 1 May 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (1) , 291-299
- https://doi.org/10.1038/sj.bjp.0702525
Abstract
α1‐adrenoceptor agonists may potentiate relaxation to β‐adrenoceptor agonists, although the mechanisms are unclear. We compared relaxations induced by β‐adrenoceptor agonists and cyclic AMP‐dependent vasodilators in rat pulmonary arteries constricted with prostaglandin F2α (PGF2α) or the α1‐adrenoceptor agonist phenylephrine (PE). In addition, we examined whether differences were related to cyclic AMP‐ or nitric oxide (NO) and cyclic GMP‐dependent pathways. Isoprenaline‐induced relaxation was substantially potentiated in arteries constricted with PE compared with PGF2α. Methoxamine was similar to PE, whereas there was no difference between PGF2α and 30 mM KCl. The potentiation was primarily due to a marked increase in the NO‐independent component of relaxation, from 9.1±1.7% for PGF2α to 55.1±4.4% for PE. NO‐dependent relaxation was also enhanced, but to a lesser extent (∼50%). Relaxation to salbutamol was almost entirely NO‐dependent in both groups, and was potentiated ∼50% by PE. Relaxation to forskolin (activator of adenylate cyclase) was also enhanced in PE constricted arteries. Part of this relaxation was NO‐dependent, but the major effect of PE was to increase the NO‐independent component. Propranolol diminished but did not abolish the potentiation. There was no difference in response to CPT cyclic AMP (membrane permeant analogue) between PE and PGF2α, suggesting that mechanisms distal to the production of cyclic AMP were unchanged. Relaxation to sodium nitroprusside (SNP) was the same for PE and PGF2α, although relaxation to acetylcholine (ACh) was slightly depressed. This implies that potentiation by PE does not involve the cyclic GMP pathway directly. Mesenteric arteries constricted with PE did not show potentiation of isoprenaline‐induced relaxation compared to those constricted with PGF2α, suggesting that this effect may be specific to the pulmonary circulation. These results clearly show that PE potentiates both the NO‐independent and ‐dependent components of cyclic AMP‐mediated relaxation in pulmonary arteries of the rat, although the effect on the former is more profound. We suggest that potentiation of both components is largely due to direct activation of adenylate cyclase via α1‐adrenoceptors, within the smooth muscle and endothelial cells respectively. British Journal of Pharmacology (1999) 127, 291–299; doi:10.1038/sj.bjp.0702525Keywords
This publication has 34 references indexed in Scilit:
- Noradrenaline, β‐adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the ratBritish Journal of Pharmacology, 1997
- Nitric oxide synthases: which, where, how, and why?Journal of Clinical Investigation, 1997
- Interaction Between α and β‐Adrenergic Receptor Agonists Modulating the Slow Ca2+‐activated K+ Current ‐ IAHP in Hippocampd NeuronsEuropean Journal of Neuroscience, 1996
- An attenuated alpha-1 potentiation of beta adrenoceptor-stimulated cyclic AMP formation after repeated saline injections in fischer 344 strain ratsLife Sciences, 1996
- COMPARISON OF THE EFFECTS OF VASOACTIVE AGENTS ON ADENYLATE CYCLASE ACTIVITY IN ENDOTHELIAL AND SMOOTH MUSCLE CELLS FROM THE SAME SPECIMEN OF FETAL BOVINE AORTAClinical and Experimental Pharmacology and Physiology, 1996
- Potentiation of Agonist‐Stimulated Cyclic AMP Accumulation by Tyrosine Kinase Inhibitors in Rat PinealocytesJournal of Neurochemistry, 1995
- Enhancement of the vasoconstrictor response to KCL by nitric oxide synthesis inhibition: A comparison with noradrenalinePharmacological Research, 1995
- Cross Talk Among Cyclic AMP, Cyclic GMP, and Ca2+ ‐Dependent Intracellular Signalling Mechanisms in Brain Capillary Endothelial CellsJournal of Neurochemistry, 1994
- The Role of Cyclic AMP and Phosphodiesterase Activity in the Mechanism of Action of Tetramethylpyrazine on Human and Dog Cardiac and Dog Coronary Arterial TissuesJournal of Pharmacy and Pharmacology, 1993
- Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endotheliumMetabolic Brain Disease, 1992